Prophylactic HPV vaccination and anal cancer

References

• Fact Sheet: Age-Adjusted SEER Incidence Rates By Cancer Site. National Cancer Institute, Surveillance, epidemiology and end results program (SEER), “anus, anal canal and anal rectum” All Ages, All Races, Male and female, 1975-2012 (SEER 9). Available from: http://seer.cancer.gov/faststats/selections.php?#Output
   Google Scholar
• Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13:487-500; PMID:22445259; http://dx.doi.org/10.1016/S1470-2045(12)70080-3
   PubMed Web of Science ®Google Scholar
• Stier EA, Sebring MC, Mendez AE, Ba FS, Trimble DD, Chiao EY. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review. Am J Obstet Gynecol 2015; 213:278-309; PMID:25797230; http://dx.doi.org/10.1016/j.ajog.2015.03.034
   PubMed Web of Science ®Google Scholar
• De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124:1626-36; PMID:19115209; http://dx.doi.org/10.1002/ijc.24116
   PubMed Web of Science ®Google Scholar
• Baricevic I, He X, Chakrabarty B, Oliver AW, Bailey C, Summers J, Hampson L, Hampson I, Gilbert DC, Renehan AG. High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis. Eur J Cancer 2015; 51:776-85; PMID:25702585; http://dx.doi.org/10.1016/j.ejca.2015.01.058
   PubMed Web of Science ®Google Scholar
• Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer 2015; 51:1732-41; PMID:26121913; http://dx.doi.org/10.1016/j.ejca.2015.06.001
   PubMed Web of Science ®Google Scholar
• Ouhoummane N, Steben M, Coutlée F, Vuong T, Forest P, Rodier C, Louchini R, Duarte E, Brassard P. Squamous anal cancer: patient characteristics and HPV type distribution. Cancer Epidemiol 2013; 37:807-12; PMID:24139594; http://dx.doi.org/10.1016/j.canep.2013.09.015
   PubMed Web of Science ®Google Scholar
• Hillman RJ, Garland SM, Gunathilake MPW, Stevens M, Kumaradevan N, Lemech C, Ward RL, Meagher A, McHugh L, Jin F, et al. Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers. Int J Cancer 2014; 135:996-1001; PMID:24497322; http://dx.doi.org/10.1002/ijc.28730
   PubMed Web of Science ®Google Scholar
• Alemany L, Saunier M, Alvarado-Cabrero I, Quirós B, Salmeron J, Shin HR, Pirog EC, Guimerà N, Hernandez-Suarez G, Felix A, et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer 2015; 136:98-107; PMID:24817381; http://dx.doi.org/10.1002/ijc.28963
   PubMed Web of Science ®Google Scholar
• Steinau M, Unger ER, Hernandez BY, Goodman MT, Copeland G, Hopenhayn C, Cozen W, Saber MS, Huang Y, Peters ES, et al. Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis 2013; 17:397-403; PMID:23609590; http://dx.doi.org/10.1097/LGT.0b013e31827ed372
   PubMed Web of Science ®Google Scholar
• Abramowitz L, Jacquard A-C, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, et al. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 2011; 129:433-9; PMID:20839262; http://dx.doi.org/10.1002/ijc.25671
   PubMed Web of Science ®Google Scholar
• McCredie MRE, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9:425-34; PMID:18407790; http://dx.doi.org/10.1016/S1470-2045(08)70103-7
   PubMed Web of Science ®Google Scholar
• Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365:1576-85; PMID:22029979; http://dx.doi.org/10.1056/NEJMoa1010971
   PubMed Web of Science ®Google Scholar
• Palefsky JM. Screening to prevent anal cancer: Current thinking and future directions. Cancer Cytopathol 2015; 123:509-10; PMID:26237741; http://dx.doi.org/10.1002/cncy.21571
   PubMed Web of Science ®Google Scholar
• Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, Jay N, Aboulafia D, Cohn DL, Einstein MH, et al. Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected Men. J Infect Dis 2010; 202:1246-53; PMID:20812850; http://dx.doi.org/10.1086/656320
   PubMed Web of Science ®Google Scholar
• Vaccine therapy in preventing Human papillomavirus infection in young HIV-positive male patients who have sex with males. In: ClinicalTrials.gov [Internet]. Available from: https://clinicaltrials.gov/ct2/show/NCT01209325?term=NCT01209325 NLM Identifier: NCT01209325.
   Google Scholar
• Swedish KA, Factor SH, Goldstone SE. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin Infect Dis 2012; 54:891-8; PMID:22291111; http://dx.doi.org/10.1093/cid/cir1036
   PubMed Web of Science ®Google Scholar
• Deshmukh AA, Chhatwal J, Chiao EY, Nyitray AG, Das P, Cantor SB. Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men. Clin Infect Dis 2015; 61:1527-35; PMID:26223993; http://dx.doi.org/10.1093/cid/civ628
   PubMed Web of Science ®Google Scholar
• Joura EA, Giuliano AR, Iversen O-E, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, et al. A 9-valent HPV vaccine against infection and intraepithelial Neoplasia in Women. N Engl J Med 2015; 372(8):711-23; PMID:25693011; http://dx.doi.org/10.1056/NEJMoa1405044
   PubMed Web of Science ®Google Scholar